Scientists from CNRS have developed new stable and effective messenger RNA (mRNA) sequences that enable cells to produce therapeutic proteins themselves, capable of inducing antibody ...

Further validating the results, University of Florida researchers found that tying cancer immunotherapies with COVID-targeted ...

Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company ...

Patients with late-stage lung and skin cancer may have just won an unlikely ally: the COVID-19 mRNA vaccine. Researchers at ...

Lung cancer and melanoma patients immunized with this formula doubled their chances of surviving three years, according to a ...

The quest for a vaccine against HIV has been going on for about 40 years — almost as long as the virus that causes AIDS has been known to scientists and the public. There has been some progress ...

The observation also marks a significant step toward a long-awaited universal cancer vaccine to boost the tumor-fighting ...

A commonly used strategy in the development of messenger RNA (mRNA) medicine is based on the destruction of disease-causing mRNA. Achieving the opposite and stabilizing health-promoting mRNA is still ...

Innorna Co., a Chinese developer of messenger RNA drugs backed by buyout firm CDH Investments, is planning an initial public ...

Shares of Arcturus Therapeutics Holdings fell sharply premarket amid fears about patient complications in the wake of a mid-stage trial of a biotech spray treatment for cystic fibrosis that had mixed ...

Interferon lambda concentrations in nasal lining fluid fell in or above the predicted therapeutic range with a nasally ...

Texas A&M Health researchers discovered that RNA drives cancer growth in translocation renal cell carcinoma (tRCC) by ...